Keywords: ec, clears, sale, altana, pharma, nycomed, european
EC clears sale of Altana Pharma to Nycomed
Article | 22 December 2006
The European Commission has cleared, under the European Union merger regulation, the proposed $5.7 billion acquisition of Altana Pharma of Germany ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
